Pro-Dex, Inc.
PDEXMedical Instruments & Supplies
$61.60−2.52%As of Oct 29vs prior close
- Market cap
- $199.2M
- P/E (TTM)
- 16.6×
- From 52W high
- −16.09%
- EPS (LTM)
- $3.64
- Revenue (LTM)
- $79.6M
- Net margin
- 15.12%
- Dividend yield
- 0.00%
Nomior Score
70
Steady ProfileSpeculativeTop 10% of the scored universe
Growth43
Quality63
Value61
Momentum96
Resilience48
Growth
+15.06%revenue a year over 9 fiscal years
FY17 $21.9MLTM $79.6M
Connections
Revenue to profitQ1 FY27
15% of revenue became net profit, down 10 pts on a year.
Latest resultsfiscal 2027 first quarter ended September 30, 2026
- Net income
- $3.0 million
- Diluted EPS
- $0.92
Net sales rose from the year-ago quarter, driven mainly by higher medical device revenue tied to the next-generation handpiece and contribution from the newly acquired APM subsidiary. Gross margin improved on favorable product mix, but operating expenses also rose, and net income declined from the prior year, which included large unrealized investment gains. Management expects to ship Monogram validation units later this fiscal year.
Who owns it
2funds